Lurasidone for the treatment of bipolar depression: an evidence-based review
Rachel Franklin,1 Sam Zorowitz,1 Andrew K Corse,1 Alik S Widge,2 Thilo Deckersbach1 1Division of Neurotherapeutics, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, 2Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambr...
Guardado en:
Autores principales: | Franklin R, Zorowitz S, Corse AK, Widge AS, Deckersbach T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6fe4be21c082423f922d613cdb1686ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lurasidone as a potential therapy for bipolar disorder
por: Woo YS, et al.
Publicado: (2013) -
Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia S, et al.
Publicado: (2012) -
The clinical utility of lurasidone in schizophrenia: patient considerations
por: Harvey PD
Publicado: (2015) -
Persistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depression
por: Penders TM, et al.
Publicado: (2013) -
Depressive mixed state: Evidence for a new form of depressive state in type I and II bipolar patients
por: Katia M’Bailara, et al.
Publicado: (2007)